Key facts
- This page summarizes Mark Stolper's Form 4 filing for Coherus BioSciences, Inc. (CHRS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Jun 2024, 18:49.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.